biospecimen__admin__batch_number	287.61.0
biospecimen__admin__bcr	Nationwide Children's Hospital
biospecimen__admin__day_of_dcc_upload	1
biospecimen__admin__disease_code	LIHC
biospecimen__admin__file_uuid	6194C106-990A-4E66-AD75-4638F8E9CF4C
biospecimen__admin__month_of_dcc_upload	7
biospecimen__admin__year_of_dcc_upload	2016
biospecimen__bio__bcr_analyte_barcode	TCGA-BW-A5NP-01A-11R
biospecimen__bio__bcr_portion_barcode	TCGA-BW-A5NP-01A-11
biospecimen__bio__bcr_sample_barcode	TCGA-BW-A5NP-01A
biospecimen__bio__biospecimen_barcode_bottom	0145631784
biospecimen__bio__day_of_creation	12
biospecimen__bio__day_of_shipment	25
biospecimen__bio__days_to_index	0
biospecimen__bio__gel_image_file	https://sharedoc.nchri.org/tcga-bcr/default.aspx
biospecimen__bio__is_derived_from_ffpe	NO
biospecimen__bio__month_of_creation	02
biospecimen__bio__month_of_shipment	03
biospecimen__bio__pathology_report_file_name	TCGA-BW-A5NP.D13029B5-B160-48FC-A556-9FBF8CAF4EDB.pdf
biospecimen__bio__plate_column	1
biospecimen__bio__plate_id	A27R
biospecimen__bio__plate_row	B
biospecimen__bio__portion_sequence	1
biospecimen__bio__quantity	3.40
biospecimen__bio__subportion_sequence	1
biospecimen__bio__vial_number	A
biospecimen__bio__volume	20.00
biospecimen__bio__year_of_creation	2013
biospecimen__bio__year_of_shipment	2013
biospecimen__shared__bcr_patient_barcode	TCGA-BW-A5NP
biospecimen__shared__patient_id	A5NP
clinical__admin__day_of_dcc_upload	22
clinical__admin__file_uuid	716C6A79-6D1E-46DC-BD7D-363BDF0CB2D4
clinical__admin__month_of_dcc_upload	12
clinical__admin__withdrawn	false
clinical__chol_lihc_shared__fetoprotein_outcome_value	143684
clinical__chol_lihc_shared__fibrosis_ishak_score	3,4 - Fibrous Speta
clinical__chol_lihc_shared__hist_hepato_carc_fact	Hepatitis B
clinical__chol_lihc_shared__vascular_tumor_cell_type	Micro
clinical__clin_shared__age_at_initial_pathologic_diagnosis	26
clinical__clin_shared__day_of_form_completion	26
clinical__clin_shared__days_to_initial_pathologic_diagnosis	0
clinical__clin_shared__eastern_cancer_oncology_group	2
clinical__clin_shared__informed_consent_verified	YES
clinical__clin_shared__measure_of_response	Clinical Progressive Disease
clinical__clin_shared__month_of_form_completion	3
clinical__clin_shared__person_neoplasm_cancer_status	WITH TUMOR
clinical__clin_shared__post_op_ablation_embolization_tx	NO
clinical__clin_shared__postoperative_rx_tx	YES
clinical__clin_shared__radiation_therapy	NO
clinical__clin_shared__residual_tumor	RX
clinical__clin_shared__tissue_prospective_collection_indicator	YES
clinical__clin_shared__tissue_retrospective_collection_indicator	NO
clinical__clin_shared__tumor_tissue_site	Liver
clinical__clin_shared__year_of_form_completion	2014
clinical__clin_shared__year_of_initial_pathologic_diagnosis	2010
clinical__lihc__adjacent_hepatic_tissue_inflammation_extent_type	Mild
clinical__lihc_nte__new_tumor_event_ablation_embo_tx	No
clinical__lihc_nte__new_tumor_event_liver_transplant	No
clinical__nte__additional_pharmaceutical_therapy	YES
clinical__nte__additional_radiation_therapy	NO
clinical__nte__days_to_new_tumor_event_after_initial_treatment	102
clinical__nte__new_neoplasm_event_occurrence_anatomic_site	Liver
clinical__nte__new_neoplasm_event_type	Extrahepatic Recurrence
clinical__nte__new_tumor_event_additional_surgery_procedure	NO
clinical__nte__new_tumor_event_after_initial_treatment	YES
clinical__rx__bcr_drug_barcode	TCGA-BW-A5NP-D42457
clinical__rx__bcr_drug_uuid	164C944A-AF81-454A-BAAE-E3F547B863F9
clinical__rx__days_to_drug_therapy_end	289
clinical__rx__days_to_drug_therapy_start	128
clinical__rx__drug_name	Nexavar
clinical__rx__therapy_ongoing	NO
clinical__rx__therapy_type	Chemotherapy
clinical__rx__tx_on_clinical_trial	NO
clinical__shared__histological_type	Hepatocellular Carcinoma
clinical__shared__history_of_neoadjuvant_treatment	No
clinical__shared__neoplasm_histologic_grade	G3
clinical__shared__other_dx	No
clinical__shared_stage__pathologic_m	M1
clinical__shared_stage__pathologic_n	N0
clinical__shared_stage__pathologic_t	T2
clinical__shared_stage__system_version	7th
gdc__access	open
gdc__acl	open
gdc__aliquots__aliquot_id	b5606d18-491c-4952-be0a-03bda11e2eab
gdc__aliquots__concentration	0.17
gdc__aliquots__source_center	23
gdc__aliquots__submitter_id	TCGA-BW-A5NP-01A-11R-A27R-13
gdc__aliquots__updated_datetime	2018-09-06T14:13:07.098771-05:00
gdc__analysis__analysis_id	4b193bcd-1481-4083-a8a4-7d654855400d
gdc__analysis__workflow_link	https://github.com/NCI-GDC/gdc-dnaseq-cwl/blob/gdc-active-submission/workflows/mirnaseq/runner.cwl
gdc__analysis__workflow_type	BCGSC miRNA Profiling
gdc__analytes__a260_a280_ratio	1.81
gdc__analytes__analyte_id	1589f080-e4f8-45ab-95bd-a2de2811e172
gdc__analytes__analyte_type	RNA
gdc__analytes__analyte_type_id	R
gdc__analytes__spectrophotometer_method	UV Spec
gdc__case_id	56a82a56-0241-4d3d-9de2-696b0c36df91
gdc__center__center_id	6eba705a-0f00-5aa2-b1d0-04dbf62100cc
gdc__center__center_type	CGCC
gdc__center__code	13
gdc__center__name	Canada's Michael Smith Genome Sciences Centre
gdc__center__namespace	bcgsc.ca
gdc__center__short_name	BCGSC
gdc__created_datetime	2018-03-20T12:37:39.749293-05:00
gdc__data_category	Transcriptome Profiling
gdc__data_format	TXT
gdc__data_type	miRNA Expression Quantification
gdc__demographic__demographic_id	0d1e527a-0b5e-5bed-aaac-0cd78f3700b6
gdc__demographic__ethnicity	hispanic or latino
gdc__demographic__gender	female
gdc__demographic__race	white
gdc__demographic__year_of_birth	1984
gdc__diagnoses__age_at_diagnosis	9809
gdc__diagnoses__classification_of_tumor	not reported
gdc__diagnoses__days_to_birth	-9809.0
gdc__diagnoses__days_to_last_follow_up	0.0
gdc__diagnoses__diagnosis_id	a62e0e69-b21e-5c47-87d4-0802a321c05c
gdc__diagnoses__last_known_disease_status	not reported
gdc__diagnoses__morphology	8170/3
gdc__diagnoses__primary_diagnosis	Hepatocellular carcinoma NOS
gdc__diagnoses__prior_malignancy	not reported
gdc__diagnoses__progression_or_recurrence	not reported
gdc__diagnoses__site_of_resection_or_biopsy	Liver
gdc__diagnoses__tissue_or_organ_of_origin	Liver
gdc__diagnoses__tumor_grade	not reported
gdc__diagnoses__tumor_stage	stage iv
gdc__diagnoses__vital_status	alive
gdc__disease_type	Adenomas and Adenocarcinomas
gdc__experimental_strategy	miRNA-Seq
gdc__exposures__exposure_id	4321a481-89eb-5c2a-8fd5-a8ce59d99d71
gdc__file_id	0ca2657a-871a-4033-9b0d-4d1d35c17195
gdc__file_name	14ae1d6b-f3d1-4db2-a838-e6213fd09e90.mirbase21.mirnas.quantification.txt
gdc__file_size	50338
gdc__input_files__data_category	Raw Sequencing Data
gdc__input_files__data_format	BAM
gdc__input_files__data_type	Aligned Reads
gdc__input_files__experimental_strategy	miRNA-Seq
gdc__input_files__platform	Illumina
gdc__md5sum	a330b35690d8f142422ce4f41966adcd
gdc__portions__is_ffpe	false
gdc__portions__portion_id	e809de4b-77e7-4529-826f-88ffe536f814
gdc__portions__portion_number	11
gdc__portions__weight	30.0
gdc__primary_site	Liver and intrahepatic bile ducts
gdc__program__dbgap_accession_number	phs000178
gdc__program__name	TCGA
gdc__program__program_id	b80aa962-9650-5110-b3eb-bd087da808db
gdc__project__disease_type	Liver Hepatocellular Carcinoma
gdc__project__primary_site	Liver
gdc__project__project_id	TCGA-LIHC
gdc__project__releasable	false
gdc__project__released	true
gdc__samples__days_to_collection	1057
gdc__samples__initial_weight	290.0
gdc__samples__oct_embedded	false
gdc__samples__pathology_report_uuid	D13029B5-B160-48FC-A556-9FBF8CAF4EDB
gdc__samples__sample_id	c13884b6-eaef-4e1c-8fa7-5fe76548d32f
gdc__samples__sample_type	Primary Tumor
gdc__samples__sample_type_id	01
gdc__slides__percent_lymphocyte_infiltration	2.0
gdc__slides__percent_monocyte_infiltration	0.0
gdc__slides__percent_necrosis	0.0
gdc__slides__percent_neutrophil_infiltration	0.0
gdc__slides__percent_normal_cells	0.0
gdc__slides__percent_stromal_cells	0.0
gdc__slides__percent_tumor_cells	100.0
gdc__slides__percent_tumor_nuclei	80.0
gdc__slides__section_location	TOP
gdc__slides__slide_id	1bf54bfa-80ac-4475-b92d-51bc1458d208
gdc__submitter_id	mirna_swap_dr11_263_MirnaExpression3c506166-7461-446f-9d43-58d41d38db60_profiling
gdc__tissue_source_site__bcr_id	NCH
gdc__tissue_source_site__code	BW
gdc__tissue_source_site__name	St. Joseph's Medical Center-(MD)
gdc__tissue_source_site__tissue_source_site_id	0e691470-b18b-5803-9e4a-ee2cfbaae7b4
gdc__treatments__treatment_id	4bdb7727-68cd-5b6b-9222-4c26dcb18061
gdc__type	mirna_expression
gdc__updated_datetime	2018-09-08T13:43:34.032262+00:00
manually_curated__data_format	BED
manually_curated__download_date	2018-11-06T09:10:40.925+01:00
manually_curated__exp_data_bed_url	ftp://bioinformatics.iasi.cnr.it/opengdc/bed/tcga/tcga-lihc/mirna_expression_quantification/b5606d18-491c-4952-be0a-03bda11e2eab-meq.bed
manually_curated__exp_metadata_url	ftp://bioinformatics.iasi.cnr.it/opengdc/bed/tcga/tcga-lihc/mirna_expression_quantification/b5606d18-491c-4952-be0a-03bda11e2eab-meq.bed.meta
manually_curated__genome_built	GRCh38
manually_curated__local_file_size	129709
manually_curated__local_md5	375d2f7ffc97e50f8761c76c0b1fd711
manually_curated__opengdc_download_date	2018-10-16T17:11:32.000854+02:00
manually_curated__opengdc_file_md5	97005b38130ec863a5f6c38a56a53015
manually_curated__opengdc_file_size	50337
manually_curated__opengdc_id	b5606d18-491c-4952-be0a-03bda11e2eab-meq
manually_curated__origin_file_size	129709
manually_curated__origin_last_modified_date	Tue Oct 16 17:52:00 CEST 2018
manually_curated__origin_md5	375d2f7ffc97e50f8761c76c0b1fd711
manually_curated__tissue_status	tumoral
